Related Experiment Video
Updated: Jul 16, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
The Difficulty Detecting Tuberculosis in a Child with Post-COVID-19 and Cerebral Palsy
Andjelka Stojkovic1,2, Irena Ilic3, Andrijana Kostic1
1University Clinical Center Clinic of Pediatrics Kragujevac Serbia, 34000 Kragujevac, Serbia.
Insights
Coinfection with COVID-19 and hypostatic pneumonia prolongs illness, leading to immune exhaustion and potential tuberculosis reactivation. Diagnosing pulmonary tuberculosis in these patients is challenging, necessitating improved diagnostic tests.
Area of Science:
- Infectious Diseases
- Pulmonology
- Immunology
Background:
- Concurrent COVID-19 and hypostatic pneumonia lead to prolonged illness characterized by persistent inflammation and immune exhaustion.
- Immune exhaustion can result in viral reactivation and secondary infections, including pulmonary tuberculosis.
- Pulmonary tuberculosis presents atypically in post-COVID-19 patients and those with spastic quadriplegic cerebral palsy, complicating diagnosis.
Purpose of the Study:
- To highlight the diagnostic challenges of pulmonary tuberculosis in the context of post-COVID-19 complications.
- To emphasize the need for improved diagnostic methods for detecting tuberculosis bacillus in immunocompromised patients.
Main Methods:
- Clinical observation of prolonged COVID-19 cases with concurrent hypostatic pneumonia.
- Analysis of atypical presentations of pulmonary tuberculosis in specific patient populations.
- Review of diagnostic difficulties including laboratory, radiological, and microbiological assessments.
Main Results:
- Pulmonary tuberculosis diagnosis and treatment were delayed due to atypical presentations and co-infections.
- Standard diagnostic methods (laboratory, radiological, microbiological) were insufficient for timely confirmation.
- Treatment for pulmonary tuberculosis was initiated late, often based on therapeutic response ('ex juvantibus').
Conclusions:
- The complex interplay of COVID-19, hypostatic pneumonia, and immunosuppression creates a challenging environment for diagnosing secondary pulmonary tuberculosis.
- Current diagnostic tools are inadequate for the early and accurate detection of tuberculosis bacillus in these patients.
- Development of novel, precise, and reliable diagnostic tests for tuberculosis is urgently required.
Abstract:
When hypostatic pneumonia is present at the same time as COVID-19 pneumonia, the clinical course is almost always prolonged (prolonged-COVID-19) due to persistent inflammation, long-term anti-inflammatory syndrome, followed by immune exhaustion, i.e., by immunosuppression and catabolic syndrome. In the immunosuppression phase, viral reactivation can be accompanied by a secondary infection, which, in this case, is pulmonary tuberculosis. Pulmonary tuberculosis in post-COVID-19 patients and in patients with spastic quadriplegic cerebral palsy does not have a typical clinical course nor laboratory, radiological, immunological, microbiological, or fiberbronchoscopic pathohistological confirmation. Due to this, the treatment of pulmonary tuberculosis was not carried out on time, postponed after the unsuccessful treatment of sepsis, post-COVID-19, and other accompanying viral (adenovirus, RSV) and bacterial (streptococcus viridans) infections. The treatment of pulmonary tuberculosis was possible only "ex juvantibus" (trial) post-COVID-19. It becomes imperative to search for a new, more precise and reliable diagnostic test for the detection of tuberculosis bacillus.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pneumonia III: Complications and Assessment

